Cannabis Cultivation Market: New Study Offers Insights for2018 – 2028

The introduced study elucidates the key indexes of Market growth which … Maricann, Inc. Aurora Cannabis; Aphria, Inc. Canopy Growth Corporation.

The study on the Cannabis Cultivation Market Research offers a profound comprehension of the market dynamics like opportunities, drivers, trends, and the challenges. The analysis further elaborates on the micro and macro-economic aspects which can be predicted to shape the rise of the Cannabis Cultivation Market throughout the forecast period (2019-2029).

The introduced study elucidates the key indexes of Market growth which contains a comprehensive analysis of CAGR development the value chain, and Porter’s Five Forces Analysis. This data will enable readers to know the qualitative growth parameters of their worldwide market.

Analytical Insights Included at the Report

  • Estimated earnings growth of the Cannabis Cultivation Marketplace during the forecast period
  • Facets expected to Help the growth of the Cannabis Cultivation Market
  • The growth potential of the Cannabis Cultivation Market in a Variety of regions
  • Consumption, pricing structure, and adoption routine of the Cannabis Cultivation
  • Company profiles of major players at the Cannabis Cultivation Market

Request Sample Report @ https://www.TMRRresearch.com/sample/sample?flag=B&rep_id=6022&source=atm

Cannabis Cultivation Market Segmentation Assessment

The development prospects of this Cannabis Cultivation Marketplace in various Regions are analyzed in the report together with information such as political, the regulatory frame, and economic outlook of each region.

Prominent players in the global Cannabis Cultivation Market are:

  • Sativa, Inc.
  • GW Pharmaceuticals plc.
  • Maricann, Inc.
  • Aurora Cannabis
  • Aphria, Inc.
  • Canopy Growth Corporation

Global Cannabis Cultivation Market: Key trends and driver

The growth in global cannabis cultivation market is fuelled by a number of trends and drivers. Some of the key ones are elaborated below.

  • Use of pot by people in diseases like cancer and major injuries is leading to growth in demand in the global cannabis cultivation market. The Food and Drug administration has approved it for treatment of two rare and severe forms of epilepsy – Dravet syndrome and Lennox-Gastaut syndrome. To add on, in a recent study – The Health Effects of Cannabis and Cannabinoids – by National Academics of Sciences, Engineering, and Medicine, researchers have found a positive correlation of cannabis with many conditions such as dementia. In another research – “In vivo Evidence for Therapeutic Properties of Cannabidiol for Alzheimer’s Disease,” by Georgia Watt and Tim Karl – a relation between the product and treatment of Alzheimer’s is established.
  • As pot tourism is catching on with people, so is demand for high quality cannabis, leading to an upward growth in the Global Cannabis Cultivation Market. States such as Colorado and Washington are seeing rise in the trend by as much as 51% since 2014. In 2016 alone, Colorado registered four million visitors (approximately). Canada is also witnessing a steady increase in pot tourism.

Global Cannabis Cultivation Market: Regional Analysis

North America is set to demonstrate remarkable growth in the Global Cannabis Cultivation market owing to the presence of two of the largest legalized markets (Canada and United States of America). Another factor contributing here is presence of major businesses such as Canopy Growth Corporation. The Ontario-based business tripled cultivation in 2018 and is set to increase it to 5 mn sq. ft. by beginning of 2020.

Global Cannabis Cultivation Market is segmented based on:

Product Outlook

  • Buds
  • Oils
  • Tinctures

Request For Discount On This Report @ https://www.TMRRresearch.com/sample/sample?flag=D&rep_id=6022&source=atm

The Report aims to resolve the subsequent doubts regarding the Cannabis Cultivation Economy:

  1. What Would be the trends that are dictating the development of the Cannabis Cultivation Market?
  2. What Is your reach of innovation in the current Cannabis Cultivation Market landscape?
  3. How Will the recent amendments in the industrial coverages in place 1 and region 2 affect the development of the market?
  4. What Is the value of the Cannabis Cultivation Market in 2029?
  5. That Regional market is predicted to witness the highest CAGR increase during the assessment period?

Reasons To Choose TMRR:

  • Powerful and prompt customer support
  • A systematic and methodical market study process
  • Unbiased insights and marketplace decisions
  • Our insights have empowered the growth of over 500 clients
  • Reports made accessible as That the demands of our clientele

Customize This Report @ https://www.TMRRresearch.com/sample/sample?flag=CR&rep_id=6022&source=atm

Related Posts:

  • No Related Posts

Medical Marijuana Market Growth Rate 2019 – Evolving Technology, Market Size, Share, Data …

Canopy Growth; Lexaria Corp. United Cannabis Corporation; Aurora Cannabis; Cannabis Sativa Inc. Cara Therapeutics Inc. GW Pharmaceuticals …
  • Cannabis Sativa Inc.

    Medical Marijuana Market Report Highlights: –

    • The report covers forecast and analysis for the market on a global and regional level.
    • The report includes the drivers and the restraints that affect the growth of the market.
    • The report discusses detailed information about the market opportunities.
    • The market is segmented on the basis of product and end-user industry which in turn is bifurcated on the regional level.
    • The key target audience for the market has been determined in the report.
    • The revenue generated by the prominent industry players has been analyzed in the report.

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/13999590

    Key Market Trends:

    Chronic Pain is the Segment under Application that is Expected to Experience the Fastest Growth during the Forecast Period

    There are many studies that have shown that medical cannabis is found to be an effective method for the treatment of chronic pain, and that it is far safer than many other options. It is an affordable, natural alternative that lacks side effects and is traditionally used to treat chronic pain. There are also several ongoing researches on medical marijuana for the treatment of chronic pain, which is expected to directly impact the growth of the market.

    Marijuana is also being used for the treatment of arthritis, as it has the potential to reduce inflammation, as well reduce pain. There is also an increasing research on medical marijuana for the treatment of cancer and commercially available cannabinoids, which are approved drugs for chemotherapy, and which are likely to augment the growth of the market. Marijuana, being an effective treatment for neuropathic pain, is expected to further rise over the forecast timeframe.

    North America Accounted for the Largest Share in the Global Market

    North America holds the major share in the medical marijuana market, and is expected to show a similar trend over the forecast period, without significant fluctuations. The surging pace of cannabis legalization in the United States is one of the key factors contributing to its increased demand. There are also many marijuana programs in the United States that have accelerated, and most of the states have started to approach medical marijuana from the perspective of good public health.

    Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/13999590

    Detailed TOC of Medical Marijuana Market Report 2019-2024:

    1 INTRODUCTION

    1.1 Study Deliverables

    1.2 Study Assumptions

    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS

    4.1 Market Overview

    4.2 Market Drivers

    4.2.1 Increasing Number of Countries Legalizing the Use of Medical Marijuana

    4.2.2 Trend of Producing Edible Products with Cannabis

    4.2.3 Favorable Reimbursement Environment and Government Support in Certain Countries

    4.3 Market Restraints

    4.3.1 Lack of Awareness about the Dosage and Medicinal Properties of Marijuana

    4.3.2 Social Stigma Related to Cannabis Use

    4.4 Porter’s Five Forces Analysis

    4.4.1 Threat of New Entrants

    4.4.2 Bargaining Power of Buyers/Consumers

    4.4.3 Bargaining Power of Suppliers

    4.4.4 Threat of Substitute Products

    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION

    5.1 By Application

    5.1.1 Chronic Pain

    5.1.2 Arthritis

    5.1.3 Migraine

    5.1.4 Cancer

    5.1.5 Other Applications

    5.2 Geography

    5.2.1 North America

    5.2.1.1 United States

    5.2.1.2 Canada

    5.2.1.3 Mexico

    5.2.2 Europe

    5.2.2.1 Germany

    5.2.2.2 United Kingdom

    5.2.2.3 France

    5.2.2.4 Italy

    5.2.2.5 Spain

    5.2.2.6 Rest of Europe

    5.2.3 Asia-Pacific

    5.2.3.1 China

    5.2.3.2 Japan

    5.2.3.3 India

    5.2.3.4 Australia

    5.2.3.5 South Korea

    5.2.3.6 Rest of Asia-Pacific

    5.2.4 Middle East & Africa

    5.2.4.1 GCC

    5.2.4.2 South Africa

    5.2.4.3 Rest of Middle East & Africa

    5.2.5 South America

    5.2.5.1 Brazil

    5.2.5.2 Argentina

    5.2.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE

    6.1 Company Profiles

    6.1.1 Canopy Growth

    6.1.2 Lexaria Corp.

    6.1.3 United Cannabis Corporation

    6.1.4 Aurora Cannabis

    6.1.5 Cannabis Sativa Inc.

    6.1.6 Cara Therapeutics Inc.

    6.1.7 GW Pharmaceuticals PLC

    6.1.8 LivWell Enlightened Health LLC

    6.1.9 Aphria Inc

    6.1.10 Medical Marijuana Inc.

    6.1.11 Lexaria Corporation

    6.1.12 United Cannabis Corporation

    6.1.13 Aurora Cannabis

    6.1.14 Cannabis Sativa Inc.

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: sales@industryresearch.co

    Our Other Reports:

    Erotic Lingerie Market Growth and Share Analysis by Leading Countries, Top Key Players, Regions, Forecast to 2019-2025

    OLED TV Industry 2019 Global Market Growth, Size, Demand, Trends, Insights and Forecast 2023

    Isopentane Market 2019| Global Overview By Industry Size, Share, Future Trends, Growth Factors and Leading Players Forecast to 2025

  • Related Posts:

    • No Related Posts

    Zacks Investment Research Upgrades Aurora Cannabis (NYSE:ACB) to Hold

    Aurora Cannabis (NYSE:ACB) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on …

    Aurora Cannabis logoAurora Cannabis (NYSE:ACB) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Thursday, Zacks.com reports.

    According to Zacks, “Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company’s purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in 24 countries across 5 continents. “

    Other analysts have also issued reports about the stock. Compass Point initiated coverage on shares of Aurora Cannabis in a research report on Monday, July 8th. They issued a “neutral” rating for the company. ValuEngine raised shares of Aurora Cannabis from a “hold” rating to a “buy” rating in a research report on Wednesday, August 21st. LADENBURG THALM/SH SH initiated coverage on shares of Aurora Cannabis in a research report on Wednesday, July 17th. They issued a “buy” rating and a $9.00 price target for the company. Stifel Nicolaus initiated coverage on shares of Aurora Cannabis in a research report on Wednesday, June 5th. They issued a “hold” rating for the company. Finally, Piper Jaffray Companies initiated coverage on shares of Aurora Cannabis in a research report on Monday, August 12th. They issued a “neutral” rating and a $7.00 price target for the company. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $8.23.

    NYSE ACB opened at $5.95 on Thursday. The company has a 50 day simple moving average of $6.06 and a 200-day simple moving average of $7.66. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.37 and a quick ratio of 1.98. The firm has a market capitalization of $6.41 billion, a price-to-earnings ratio of -27.05 and a beta of 2.47. Aurora Cannabis has a 52-week low of $4.58 and a 52-week high of $12.52.

    A number of institutional investors and hedge funds have recently modified their holdings of ACB. Mackey Komara & Dankovich LLC bought a new position in Aurora Cannabis during the second quarter valued at approximately $27,000. Executive Wealth Management LLC raised its position in Aurora Cannabis by 102.1% during the second quarter. Executive Wealth Management LLC now owns 3,900 shares of the company’s stock valued at $30,000 after acquiring an additional 1,970 shares in the last quarter. Kistler Tiffany Companies LLC raised its position in Aurora Cannabis by 77.9% during the second quarter. Kistler Tiffany Companies LLC now owns 4,075 shares of the company’s stock valued at $32,000 after acquiring an additional 1,785 shares in the last quarter. Resources Investment Advisors LLC. raised its position in Aurora Cannabis by 825.7% during the second quarter. Resources Investment Advisors LLC. now owns 4,962 shares of the company’s stock valued at $39,000 after acquiring an additional 4,426 shares in the last quarter. Finally, Manchester Financial Inc. bought a new position in Aurora Cannabis during the second quarter valued at approximately $43,000. 8.89% of the stock is currently owned by hedge funds and other institutional investors.

    Aurora Cannabis Company Profile

    Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

    Recommended Story: Sell-Side Analysts

    Get a free copy of the Zacks research report on Aurora Cannabis (ACB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

    Analyst Recommendations for Aurora Cannabis (NYSE:ACB)

    Receive News & Ratings for Aurora Cannabis Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Aurora Cannabis and related companies with MarketBeat.com’s FREE daily email newsletter.

    Related Posts:

    • No Related Posts

    Planas: Marijuana Markets: A POTcast, Saturday, Sept. 14

    Aurora Cannabis ditched it’s 10.5% stake in The Green Organic Dutchman (TGOD). Instead, Aurora bought a private organic producer: Whistler …

    Marijuana Markets: A POTcast features Banyan Hill Publishing analyst Anthony Planas, bringing you the latest cannabis industry news and investment advice.

    New deals in the U.S and Canada point to evolution in the cannabis sector. Aurora Cannabis ditched it’s 10.5% stake in The Green Organic Dutchman (TGOD). Instead, Aurora bought a private organic producer: Whistler Cannabis Co. Medicine Man Technologies bought up 22 dispensaries in the past week, despite its balance sheet’s shortcoming.

    Editor’s note: The POTcast used to run on Thursdays but we’re switching it up to Saturdays moving forward.

    Check back each Thursday afternoon for Marijuana Markets: A POTcast, here on Money and Markets. In addition to Planas’ YouTube channel and his article feed at BanyanHill.com, you can also follow along each day on Twitter @ThePotStockGuru, where Planas serves up his takes on the most important news to cannabis investors.

    Share your concerns, comments and questions for Anthony below.

    Related Posts:

    • No Related Posts

    Aurora Cannabis (TSE:ACB) Shares Down 7.4%

    Aurora Cannabis Inc (TSE:ACB) traded down 7.4% during mid-day trading on Thursday . The company traded as low as C$7.60 and last traded at …

    Aurora Cannabis logoAurora Cannabis Inc (TSE:ACB) traded down 7.4% during mid-day trading on Thursday . The company traded as low as C$7.60 and last traded at C$7.88, 6,255,901 shares traded hands during trading. A decline of 37% from the average session volume of 9,951,871 shares. The stock had previously closed at C$8.51.

    Separately, Desjardins lowered their target price on Aurora Cannabis from C$16.50 to C$14.00 and set a “buy” rating for the company in a research note on Friday. One analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of C$14.17.

    The business has a 50 day moving average of C$8.02 and a 200-day moving average of C$10.20. The company has a current ratio of 2.37, a quick ratio of 1.80 and a debt-to-equity ratio of 14.55. The firm has a market capitalization of $7.86 billion and a P/E ratio of -31.23.

    Aurora Cannabis Company Profile (TSE:ACB)

    Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

    Read More: How to Trade Using Analysts Ratings

    Receive News & Ratings for Aurora Cannabis Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Aurora Cannabis and related companies with MarketBeat.com’s FREE daily email newsletter.

    Related Posts:

    • No Related Posts